Researchers find micro-gene that protects the brain from developing epilepsy
Increased levels of a micro-RNA could have a protective effect that explains why identical stressors trigger seizures in some people but not in others
On December 16, 1997, hundreds of Japanese children were brought to hospital suffering from epilepsy-like seizures. They all had one thing in common: they had been watching an episode of the Pokémon TV show when their symptoms began. Doctors determined that their symptoms were triggered by five seconds of intensely bright flashing lights on the popular TV program. But why did the lights affect a few hundred children while thousands of other viewers were unharmed?
In new research published in the Proceedings of the National Academy of Sciences, a team of researchers headed by Prof. Hermona Soreq at the Hebrew University of Jerusalem sought to answer this question. Drawing on her previous research, Prof. Soreq, the Charlotte Slesinger Professor of Molecular Neuroscience at the Edmond and Lily Safra Center for Brain Sciences and the Alexander Silberman Institute of Life Sciences, hypothesized that healthy brains may be protected from epileptic seizures by rapidly produced molecules called short RNAs, or microRNAs (miRs). MicroRNAs are a recently-discovered class of non-coding RNAs that can prevent genes from expressing particular proteins.
To test this idea, Soreq and her colleagues at the Hebrew University developed a transgenic mouse producing unusually high amounts of one micro-RNA called miR-211, which the researchers predicted was involved. The levels of this molecule could be gradually lowered by administering the antibiotic Doxycycline, enabling tests of its potency to avoid epilepsy.
Working with colleagues at Ben-Gurion University of the Negev in Israel and Dalhousie University in Canada, they suppressed excess miR-211 production in the engineered mice to the levels found in normal brains. Within four days, this caused the mice to display electrically-recorded epilepsy and hypersensitivity to epilepsy-inducing compounds. “Dynamic changes in the amount of miR-211 in the forebrains of these mice shifted the threshold for spontaneous and pharmacologically induced seizures, alongside changes in the cholinergic pathway genes,” said Prof. Soreq.
These findings indicated that mir-211 plays a beneficial role in protecting the brain from epileptic seizures in the engineered mice.
Noting that miR-211 is known to be elevated in the brains of Alzheimer’s patients who are at high risk for epilepsy, the researchers suspect that in human brains as well, elevated miR-211 may act as a protective mechanism to reduce the risk of epileptic seizures.
“It is important to discover how only some people’s brains present a susceptibility to seizures, while others do not, even when subjected to these same stressors,” said Prof. Soreq. In searching for the physiological mechanisms that allow some people’s brains to avoid epilepsy, we found that increased levels of micro-RNA 211 could have a protective effect.”
According to the researchers, recognizing the importance of miR-211 could open new avenues for diagnosing and interfering with epilepsy. By understanding how miR-211 affects seizure thresholds, scientists could potentially develop therapeutics that lead to greater miR-211–production.
Participating researchers are affiliated with the following institutions: The Alexander Silberman Institute of Life Sciences and The Edmond and Lily Safra Center for Brain Sciences at The Hebrew University of Jerusalem, Israel; Department of Physiology and Cell Biology and Department of Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben-Gurion University of the Negev; and Department of Medical Neuroscience, Dalhousie University, Canada. The authors thank the Netherlands Brain Bank for human-derived samples.
The Hebrew University of Jerusalem is Israel’s leading academic and research institution, producing one-third of all civilian research in Israel. For more information, visit http://new.huji.ac.il/en.
# # #
CITATION: Dynamic changes in murine forebrain miR-211 expression associate with cholinergic imbalances and epileptiform activity. Uriya Bekenstein, Nibha Mishra, Dan Z. Milikovsky, Geula Hanin, Daniel Zelig, Liron Sheintuch, Amit Berson, David S. Greenberg, Alon Friedman, and Hermona Soreq. PNAS Early Edition, June 5, 2017. Doi:10.1073/pnas.1701201114. Link: www.pnas.org/cgi/doi/10.1073/pnas.1701201114
SUPPORT: The research was supported by grants to various researchers from: European Research Council Advanced Award 321501; European Union’s Seventh Framework Program FP7/2007–2013 Grant 602102, EPITARGET; Israeli Ministry of Science, Technology and Space Grant 53140; Legacy Heritage Science Initiative of the Israel Science Foundation Grants 817/13 and 717/15; the Planning and Budgeting Committee Q:35 and the Edmond and Lily Safra Center for Brain Sciences postdoctoral fellowship; and the Howard and Diana Wendy Pre-doctoral Fellowship.
Health Canal avoids using tertiary references. We have strict sourcing guidelines and rely on peer-reviewed studies, academic researches from medical associations and institutions. To ensure the accuracy of articles in Health Canal, you can read more about the editorial process here